Three or more routes for leukocyte migration into the central nervous system
暂无分享,去创建一个
[1] P PamelaSwain,et al. A new view , 2004 .
[2] W. Fierz,et al. T cell approach to demyelinating diseases , 2004, Springer Seminars in Immunopathology.
[3] R. Ransohoff,et al. Human cerebrospinal fluid central memory CD4+ T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] David H. Miller,et al. A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.
[5] Christophe Longépé. The participants and their roles , 2003 .
[6] L. Boon,et al. Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs1 , 2002, The Journal of Immunology.
[7] Rena Li,et al. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide , 2002 .
[8] G. Garden. Microglia in human immunodeficiency virus‐associated neurodegeneration , 2002, Glia.
[9] R. Veerhuis,et al. Neuroinflammation in Alzheimer's disease and prion disease , 2002, Glia.
[10] A. Cardona,et al. γ/δ T Cell-Deficient Mice Exhibit Reduced Disease Severity and Decreased Inflammatory Response in the Brain in Murine Neurocysticercosis , 2002, The Journal of Immunology.
[11] K. Frei,et al. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. , 2002, The Journal of infectious diseases.
[12] R. Rudick,et al. T‐cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking , 2002, Clinical and experimental immunology.
[13] C. Janeway,et al. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system , 2002, Journal of Neuroimmunology.
[14] S. Jander,et al. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain , 2002, Journal of Neuroimmunology.
[15] P. Kubes,et al. Overlapping Roles of P-Selectin and α4 Integrin to Recruit Leukocytes to the Central Nervous System in Experimental Autoimmune Encephalomyelitis1 , 2002, The Journal of Immunology.
[16] L. Massacesi. Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy , 2002, Clinical Neurology and Neurosurgery.
[17] P. Stevenson,et al. Uncoupling of virus-induced inflammation and anti-viral immunity in the brain parenchyma. , 2002, The Journal of general virology.
[18] R. Ransohoff,et al. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion , 2002, Journal of neuroscience research.
[19] K. Matsushima,et al. Neutralization of IFN‐inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis , 2002, European journal of immunology.
[20] H. Neumann,et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases , 2002, Trends in Neurosciences.
[21] Kouji Matsushima,et al. Pivotal Role of Dendritic Cell–derived CXCL10 in the Retention of T Helper Cell 1 Lymphocytes in Secondary Lymph Nodes , 2002, The Journal of experimental medicine.
[22] M. Weller,et al. A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape1 , 2002, The Journal of Immunology.
[23] Eugene C. Butcher,et al. Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors1 , 2002, The Journal of Immunology.
[24] G. Gores,et al. Mechanisms of hepatotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[25] B. Engelhardt,et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. , 2002, The Journal of clinical investigation.
[26] T. Smirnova,et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections , 2002, Journal of Neuroimmunology.
[27] J. Cyster,et al. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. , 2002, Immunity.
[28] C. Brosnan,et al. γδ T Cells Express Activation Markers in the Central Nervous System of Mice with Chronic-relapsing Experimental Autoimmune Encephalomyelitis , 2001 .
[29] R. Egleton,et al. Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier , 2001, Trends in Neurosciences.
[30] B. Rollins. Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease. , 2001, The Journal of clinical investigation.
[31] Steffen Jung,et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. , 2001, The Journal of clinical investigation.
[32] J. Goverman,et al. A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis , 2001, The Journal of experimental medicine.
[33] B. Engelhardt,et al. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. , 2001, The Journal of clinical investigation.
[34] A. Falus,et al. Inhibition of Antigen‐Specific T Cell Trafficking into the Central Nervous System via Blocking PECAM1/CD31 Molecule , 2001, Journal of neuropathology and experimental neurology.
[35] S. Kunkel,et al. EncephalomyelitisDuring Experimental Autoimmune Accumulation in the Central Nervous System T Cell + Control of Encephalitogenic CD4 -Inducible Protein-10) g CXCL10 (IFN-and , 2001 .
[36] James J. Campbell,et al. Unique Subpopulations of CD56+ NK and NK-T Peripheral Blood Lymphocytes Identified by Chemokine Receptor Expression Repertoire1 , 2001, The Journal of Immunology.
[37] H. Lassmann,et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. , 2001, Immunity.
[38] V. Kuchroo,et al. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. , 2001, The Journal of clinical investigation.
[39] W. Hickey,et al. CXC Chemokine Receptor-2 Ligands Are Required for Neutrophil-Mediated Host Defense in Experimental Brain Abscesses1 , 2001, The Journal of Immunology.
[40] B. Rollins,et al. Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.
[41] C. Janeway,et al. CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis. , 2001, Immunity.
[42] V. Kostulas,et al. Two subsets of dendritic cells are present in human cerebrospinal fluid. , 2001, Brain : a journal of neurology.
[43] J. Cyster,et al. Chemokines as regulators of T cell differentiation , 2001, Nature Immunology.
[44] M B Segal,et al. Transport of nutrients across the choroid plexus , 2001, Microscopy research and technique.
[45] P. Kubes,et al. A Role for Platelets and Endothelial Selectins in Tumor Necrosis Factor-&agr;–Induced Leukocyte Recruitment in the Brain Microvasculature , 2000, Circulation research.
[46] G. Krissansen,et al. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule‐1, given early in the course of disease progression , 2000, Immunology and cell biology.
[47] B. Serafini,et al. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. , 2000, The American journal of pathology.
[48] H. Weiner,et al. Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.
[49] J. Goverman,et al. In Situ Tolerance within the Central Nervous System as a Mechanism for Preventing Autoimmunity , 2000, The Journal of experimental medicine.
[50] W. Kuziel,et al. Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.
[51] Hans Lassmann,et al. Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.
[52] H. Weiner,et al. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent , 2000, European journal of immunology.
[53] W. Hickey,et al. Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. , 2000, The American journal of pathology.
[54] J. Ghersi-Egea,et al. Choroid Plexus in the Central Nervous System: Biology and Physiopathology , 2000, Journal of neuropathology and experimental neurology.
[55] C. Janeway,et al. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. , 2000, Brain : a journal of neurology.
[56] E. Butcher,et al. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. , 2000, Current opinion in immunology.
[57] G. Reichmann,et al. Phenotype and Functions of Brain Dendritic Cells Emerging During Chronic Infection of Mice with Toxoplasma gondii1 , 2000, The Journal of Immunology.
[58] W. Kuziel,et al. Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein‐1α or its CCR5 receptor , 2000, European journal of immunology.
[59] E. Leung,et al. β7 integrins contribute to demyelinating disease of the central nervous system , 2000, Journal of Neuroimmunology.
[60] G. Nuki,et al. CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease , 1999, Immunology.
[61] Jacqueline Palace,et al. The effect of anti-α4 integrin antibody on brain lesion activity in MS , 1999, Neurology.
[62] I. Weissman,et al. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[63] W. Hickey,et al. Leukocyte traffic in the central nervous system: the participants and their roles. , 1999, Seminars in immunology.
[64] P. McMenamin,et al. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations , 1999, The Journal of comparative neurology.
[65] M. Boulton,et al. Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the rat. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[66] A. Cardona,et al. Development of an Animal Model for Neurocysticercosis: Immune Response in the Central Nervous System Is Characterized by a Predominance of γδ T Cells , 1999, The Journal of Immunology.
[67] E. Butcher,et al. L-selectin–mediated Leukocyte Adhesion In Vivo: Microvillous Distribution Determines Tethering Efficiency, But Not Rolling Velocity , 1999, The Journal of experimental medicine.
[68] B. Engelhardt,et al. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. , 1998, The Journal of clinical investigation.
[69] Y. Chen,et al. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice. , 1998, Cellular immunology.
[70] P. Loetscher,et al. Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.
[71] R. Weller. Pathology of Cerebrospinal Fluid and Interstitial Fluid of the CNS: Significance for Alzheimer Disease, Prion Disorders and Multiple Sclerosis , 1998, Journal of neuropathology and experimental neurology.
[72] Christoph Schaniel,et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.
[73] M. Pfaff,et al. Integrin affinity modulation. , 1998, Trends in cell biology.
[74] V. Perry,et al. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood–brain barrier breakdown , 1998, Current Biology.
[75] W. Hickey,et al. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. , 1998, Journal of immunology.
[76] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[77] K C Lin,et al. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents. , 1998, Current opinion in chemical biology.
[78] B. Engelhardt,et al. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. , 1997, Blood.
[79] James J. Campbell,et al. Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis , 1997, The Journal of cell biology.
[80] S. Karlik,et al. Evidence for a prolonged role of alpha sub 4 integrin throughout active experimental allergic encephalomyelitis , 1996, Neurology.
[81] V. Perry,et al. Recombinant Human Adenovirus with Rat MIP‐2 Gene Insertion Causes Prolonged PMN Recruitment to the Murine Brain , 1996, The European journal of neuroscience.
[82] V. Perry,et al. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system , 1996, Neuroscience.
[83] B. Trapp,et al. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. , 1996, The Journal of clinical investigation.
[84] B. Engelhardt,et al. Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways , 1996, Brain pathology.
[85] T. Mayadas,et al. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. , 1996, The Journal of clinical investigation.
[86] M. Edsbagge,et al. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid , 1995, Journal of Neuroimmunology.
[87] R. Strieter,et al. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. , 1995, Journal of immunology.
[88] Y. Ron,et al. Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis , 1995, Journal of Neuroimmunology.
[89] V. Perry,et al. Inflammation in the nervous system , 1995, Current Opinion in Neurobiology.
[90] E. Butcher,et al. A central role for microvillous receptor presentation in leukocyte adhesion under flow , 1995, Cell.
[91] M. Miyasaka,et al. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. , 1995, Cellular immunology.
[92] S. Karlik,et al. A monoclonal antibody to α4 integrin suppresses and reverses active experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.
[93] E. Berg,et al. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow , 1995, Cell.
[94] C. Polman,et al. Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals , 1995, Journal of Neuroimmunology.
[95] Y. Ron,et al. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. , 1995, Journal of neuroimmunology.
[96] M. Schwartz,et al. Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.
[97] J. Olschowka,et al. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis , 1994, Journal of Neuroimmunology.
[98] B. Engelhardt,et al. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. , 1994, The American journal of pathology.
[99] B. Trapp,et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions , 1994, Journal of Neuroimmunology.
[100] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[101] V. Kuchroo,et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. , 1993, Journal of immunology.
[102] G. Hansson,et al. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls , 1993, Annals of neurology.
[103] H. Hartung,et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM‐1 , 1993, Annals of neurology.
[104] Changhee Kim,et al. Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice , 1993, Journal of Neuroimmunology.
[105] A. Cross,et al. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis , 1993, Journal of Neuroimmunology.
[106] M. Miyasaka,et al. ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine-induced inflammation of the central nervous system , 1993, Journal of Neuroimmunology.
[107] J. Rose,et al. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α , 1993, Journal of Neuroimmunology.
[108] H. Lassmann,et al. Bone marrow derived elements and resident microglia in brain inflammation , 1993, Glia.
[109] C. Janeway,et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.
[110] V. Perry,et al. The inflammatory response in the CNS , 1992, Neuropathology and applied neurobiology.
[111] R O Weller,et al. Pathways of Fluid Drainage from the Brain ‐ Morphological Aspects and Immunological Significance in Rat and Man , 1992, Brain pathology.
[112] T. Owens,et al. Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RBlow CD4+ T cells that induce experimental allergic encephalomyelitis , 1992, Journal of Neuroimmunology.
[113] F. Sánchez‐Madrid,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.
[114] P. Knopf,et al. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. , 1992, Immunology today.
[115] W. Hickey. Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation , 1991, Brain pathology.
[116] B. Uitdehaag,et al. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages , 1990, The Journal of experimental medicine.
[117] Sunhee C. Lee,et al. Multiple Sclerosis: A Role for Astroglia in Active Demyelination Suggested by Class II MHC Expression and Ultrastructural Study , 1990, Journal of neuropathology and experimental neurology.
[118] B. Johansson,et al. Immune Response in Deep Cervical Lymph Nodes and Spleen in the Mouse after Antigen Deposition in Different Intracerebral Sites , 1988, Scandinavian journal of immunology.
[119] W. Hickey,et al. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.
[120] W. Griffin,et al. Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege , 1985, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[121] D. Linthicum,et al. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. , 1982, Cellular immunology.
[122] C. Brosnan,et al. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. , 1981, Journal of immunology.